• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Chile: Sinopharm vaccination effficiency data

Shiloh

Editor, Senior Moderator
Source: https://www.scmp.com/news/china/sci...-vaccination-drive-adds-sinovac-efficacy-data

Chile Covid-19 vaccination drive adds to Sinovac efficacy data

As the country grapples with rising infections, results from its vaccinated population echo Brazil?s trial of the Chinese jab
The 56.5 per cent rate of effectiveness is lower than some rivals, but still higher than World Health Organization guidelines
Holly Chik
Eduardo Baptista
Holly Chik and Eduardo Baptista
Published: 2:00pm, 9 Apr, 2021
Updated: 4:41pm, 9 Apr, 2021

Chile has provided a real-time demonstration of the effectiveness of Chinese firm Sinovac?s Covid-19 vaccine, with its vaccination drive results showing it to be 56.5 per cent effective two weeks after the second dose. The findings were in line with Phase 3 trial results of the vaccine in Brazil , which found an efficacy rate of around 50 per cent.

But the study by the University of Chile also found that one dose of the Sinovac jab was only 3 per cent effective against infection, underscoring the need to get fully vaccinated. Efficacy rises to 27.7 per cent within two weeks after the second jab, reaching 56.5 per cent a fortnight later, according to the university...
 
Back
Top